| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Diabetes Research Institute at the Heinrich Heine University, Dusseldorf, Germany
Address all correspondence and requests for reprints to: Hans Hauner, M.D., Diabetes Research Institute, Heinrich Heine University, Aufm Hennekamp 65, D-40225 Duesseldorf, Germany. E-mail: hauner{at}dfi.uni-duesseldorf.de
Tumor necrosis factor-
(TNF) inhibits fat cell differentiation and
may also mediate insulin resistance in adipocytes. Both TNF receptors
are expressed in adipose tissue, but it is unknown how both receptors
are involved in these biological functions. We therefore studied the
effect of receptor-specific TNF muteins on adipose differentiation and
insulin-stimulated glucose transport of in vitro
differentiated human adipocytes in primary culture. Adipocyte precursor
cells exposed to the 60-kDa TNF receptor (p60-TNFR)-specific
TNFR32W-S86T showed a marked decrease in the percentage of
differentiating cells in response to adipogenic factors as well as a
reduction in peroxisome proliferator-activated receptor-
2 (PPAR
2)
messenger RNA (mRNA) and glycerophosphate dehydrogenase (GPDH)
activity, but increased endogenous TNF mRNA expression. When cells were
incubated with the p80-TNFR-specific TNFD143N-A145R,
adipogenesis and PPAR
2 mRNA expression were stimulated, GPDH
activity was unchanged, and TNF mRNA was completely suppressed.
Insulin-stimulated 2-deoxy-D-glucose transport was
inhibited by both muteins. The p60-TNFR-mediated inhibition increased
continuously during 6 h of treatment and was associated with a
down-regulation of glucose transporter-4 (GLUT4) mRNA and GLUT4
protein, whereas the p80-TNFR-specific mutein caused a transient
increase in GLUT4 mRNA, but did not alter GLUT4 protein expression
after a 24-h incubation. We conclude that p60-TNFR mediates the
antiadipogenic effect as well as the down-regulation of GLUT4 by TNF,
thereby leading to long-term inhibition of insulin-stimulated glucose
transport. In contrast, activation of the p80-TNFR induces an
adipogenic effect and transiently up-regulates GLUT4 expression. Here,
the acute inhibition of insulin-stimulated glucose transport may be
induced by interference with the insulin signaling pathway.
This article has been cited by other articles:
![]() |
E. Maury, L. Noel, R. Detry, and S. M. Brichard In Vitro Hyperresponsiveness to Tumor Necrosis Factor-{alpha} Contributes to Adipokine Dysregulation in Omental Adipocytes of Obese Subjects J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Greenstein, K. Khavandi, S. B. Withers, K. Sonoyama, O. Clancy, M. Jeziorska, I. Laing, A. P. Yates, P. W. Pemberton, R. A. Malik, et al. Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients Circulation, March 31, 2009; 119(12): 1661 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liang, B. Yin, H. Zhang, S. Zhang, Q. Zeng, J. Wang, X. Jiang, L. Yuan, C.-Y. Wang, and Z. Li Blockade of Tumor Necrosis Factor (TNF) Receptor Type 1-Mediated TNF-{alpha} Signaling Protected Wistar Rats from Diet-Induced Obesity and Insulin Resistance Endocrinology, June 1, 2008; 149(6): 2943 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Serino, R. Menghini, L. Fiorentino, R. Amoruso, A. Mauriello, D. Lauro, P. Sbraccia, M. L. Hribal, R. Lauro, and M. Federici Mice Heterozygous for Tumor Necrosis Factor-{alpha} Converting Enzyme Are Protected From Obesity-Induced Insulin Resistance and Diabetes Diabetes, October 1, 2007; 56(10): 2541 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Park, J. R. Berggren, M. W. Hulver, J. A Houmard, and E. P. Hoffman GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle Physiol Genomics, October 11, 2006; 27(2): 114 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Good, F. M Newell, L. M Haupt, J. P Whitehead, L. J Hutley, and J. B Prins TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue -- influence of BMI and adipose distribution Diabetes and Vascular Disease Research, May 1, 2006; 3(1): 26 - 33. [Abstract] [PDF] |
||||
![]() |
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al. Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deb, S. Amin, A. G. Imir, M. B. Yilmaz, T. Suzuki, H. Sasano, and S. E. Bulun Estrogen Regulates Expression of Tumor Necrosis Factor Receptors in Breast Adipose Fibroblasts J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4018 - 4024. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pandey, G. Tuncman, G. S. Hotamisligil, and F. Samad Divergent Roles for p55 and p75 TNF-{alpha} Receptors in the Induction of Plasminogen Activator Inhibitor-1 Am. J. Pathol., March 1, 2003; 162(3): 933 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Banerjee, M. W. Feinberg, M. Watanabe, S. Gray, R. L. Haspel, D. J. Denkinger, R. Kawahara, H. Hauner, and M. K. Jain The Kruppel-like Factor KLF2 Inhibits Peroxisome Proliferator-activated Receptor-gamma Expression and Adipogenesis J. Biol. Chem., January 17, 2003; 278(4): 2581 - 2584. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Zhang, S. Kumar, A. H. Barnett, and M. C. Eggo Dexamethasone Inhibits Tumor Necrosis Factor-{{alpha}}-Induced Apoptosis and Interleukin-1{beta} Release in Human Subcutaneous Adipocytes and Preadipocytes J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2817 - 2825. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |